重置

全部指南(2706)

2002CDC预防HIV感染病人机会性感染指南

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) 感染科,皮肤性病科 2002-06-14
Provides advice on the prevention of specific bacterial, viral, and fungal opportunistic infections in persons infected with HIV.

隐球菌病治疗的实用指南

美国感染病学会(IDSA,Infectious Diseases Society of America) 感染科 2000-04-01
The importance of initial amphotericin-B-based combination induction therapy for both non-HIV and HIV-associated cryptococcal meningitis is emphasised. Amphotericin-B formulation, second drug (fluconazole or flucytosine), and duration of induction may vary. Consolidation and maintenance treatment is with fluconazole. The aggressive management of raised intracranial pressure is advocated by means of daily lumbar punctures, based on a retrospective analysis of the last large U.S. trial. 

2010 NHS 护师指南—鼻出血(鼻衄)

英国国民健康服务(NHS,National Health Service) 血液科,呼吸科,耳鼻咽喉科 2010-01-01
英国国家健康中心发布的关于鼻出血的指南,包括检查和处理。

2009HPA 英国抗生素预防和治疗使用时间表

英国健康保护局(HPA,Health Protection Agency) 感染科 2009-01-01
Provides recommendations on antibiotic dosing and schedule for prophylaxis and treatment of deliberately-released Brucella.

2006 WHO人类和动物布鲁氏菌病

世界卫生组织(WHO,The World Health Organization) 感染科 2006-07-01
Provides comprehensive information on the clinical manifestations of brucellosis in both humans and animals, including detailed recommendations on diagnosing the infection.

1995 中国霍乱诊断标准及处理原则

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) 感染科 1995-01-01
  根据《中华人民共和国传染病防治法》和《中华人民共和国传染病防治法实施办法》的规定,制定本病的诊断标准及处理原则。 本标准规定了霍乱的诊断标准,对病人、疫点、疫区的处理原则等,并推荐了对霍乱的病原学检查、血清免疫学检查、霍乱弧菌的鉴定和分型方法以及对病人的补液疗法等。 本标准适用于全国各级卫生防疫、医疗保健机构对由01群和0139群霍乱弧菌引起的霍乱的诊断和处理。

2007 WHO 霍乱预防和控制:世界卫生组织条例和建议

世界卫生组织(WHO,The World Health Organization) 感染科 2007-01-01
Cholera is an acute enteric infection caused by the ingestion of bacterium Vibrio cholerae present in faecally contaminated water or food. Primarily linked to insufficient access to safe water and proper sanitation, its impact can be even more dramatic  in areas where basic environmental infrastructures are disrupted or have been destroyed. Countries facing complex emergencies are particularly vulnerable to cholera outbreaks. Massive displacement of IDPs or refugees to overcrowded settings, where the provision of potable water and sanitation is challenging, constitutes also a risk factor. In consequence, it is of paramount importance to be able to rely on accurate surveillance data to monitor the evolution of the outbreak and to put in place adequate intervention measures Coordination of the different sectors involved is essential, and WHO calls for the cooperation of all to limit the effect of cholera on populations. 

2004 WHO/UNICEF急性腹泻临床管理

世界卫生组织(WHO,The World Health Organization) 感染科 2004-01-01
  Two recent advances in managing diarrhoeal disease – newly formulated oral rehydrationsalts (ORS) containing lower concentrations of glucose and salt, and success in using zincsup plementation – can drastically reduce the number of child deaths. The new methods,used in addition to prevention and treatment of dehydration with appropriate fluids, breastfeeding, continued feeding and selective use of antibiotics, will reduce the duration and severity of diarrhoeal episodes and lower their incidence. Families and communities are key to achieving the goals set for managing the disease by making the new recommendations routine practice in the home and health facility.

1999CDC 美国流行性霍乱和痢疾的实验室诊断方法

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) 感染科 1999-01-01
Cholera and dysentery have afflicted humankind for centuries. The epidemics they cause have affected the outcome of wars and the fates of countries. In much of the world, epidemic cholera and dysentery are uncommon, but during the past decade these two diseases have re-emerged as causes of significant morbidity and mortality in many developing countries.

1992 CDC美国霍乱临床指南

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) 感染科 1992-03-01
UNTIL recently, cholera has been rare in the Americas. However, epidemic cholera appeared in Peru in January 1991 and spread rapidly through Latin America. In the first year of this epidemic, 17 cases of cholera that were associated with travel to Latin America were reported in the United States. More cases are likely to be seen. Although no spread from these imported cases has occurred, it is possible that some areas of the United States with poor sanitary conditions may be at risk for limited continued transmission of cholera. This article reviews the methods for recognitiondiagnosis, and treatment of cholera.